Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease
- 1 October 1998
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 115 (4) , 1006-1009
- https://doi.org/10.1016/s0016-5085(98)70274-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's DiseaseNew England Journal of Medicine, 1997
- Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroupGastroenterology, 1996
- Serological markers to differentiate between ulcerative colitis and Crohn's disease.Journal of Clinical Pathology, 1995
- Indeterminate colitisDiseases of the Colon & Rectum, 1995
- Restorative proctocolectomy and indeterminate colitisThe American Journal of Surgery, 1994
- Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance.Gut, 1992
- A New Type of Perinuclear Anti-Neutrophil Cytoplasmic Antibody (p-ANCA) in Active Ulcerative Colitis but not in Crohn's DiseaseImmunobiology, 1990
- Serum Antibodies Reactive with Saccharomyces cerevisiae in Inflammatory Bowel Disease: Is IgA Antibody a Marker for Crohn’s Disease?International Archives of Allergy and Immunology, 1990
- Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease.BMJ, 1988
- Overlap in the spectrum of non-specific inflammatory bowel disease--'colitis indeterminate'.Journal of Clinical Pathology, 1978